Qiji Investment
齐济投资
Qiji InvestmentFund
齐济投资
No graph yet
Mentioned in 3 articles
Coverage
5Y News | Zai Ling Bio Completes Nearly RMB 400 Million Series B+ Round
Accelerating the buildout of an innovative drug pipeline built on differentiated molecular scaffolds and novel targets, with a commitment to addressing unmet clinical needs.
五源资本·Zenitar Closes Nearly RMB 400 Million Series B+ Round, Multiple Global First-in-Class Drugs Enter Pivotal Clinical Trials
Structural Biology and AI-Driven Innovative Drug Discovery and Development
高榕创投·WeLing Medical Completes Angel Plus Round to Advance Fully Implantable Medical-Grade Brain-Computer Interface System
Accelerating the clinical translation of brain-computer interface technology.
高榕创投·
